Towards High-throughput Immunomics for Infectious Diseases: Use of Next-generation Peptide Microarrays for Rapid Discovery and Mapping of Antigenic Determinants

Santiago J. Carmona, Morten Nielsen, Claus Schafer-Nielsen, Juan Mucci, Jaime Altcheh, Virginia Balouz, Valeria Tekiel, Alberto C. Frasch, Oscar Campetella, Carlos A. Buscaglia, Fernán Agüero

    Research output: Contribution to journalJournal articleResearchpeer-review

    322 Downloads (Pure)

    Abstract

    Complete characterization of antibody specificities associated to natural infections is expected to provide a rich source of serologic biomarkers with potential applications in molecular diagnosis, follow-up of chemotherapeutic treatments, and prioritization of targets for vaccine development. Here, we developed a highly-multiplexed platform based on next-generation high-density peptide microarrays to map these specificities in Chagas Disease, an exemplar of a human infectious disease caused by the protozoan Trypanosoma cruzi. We designed a high-density peptide microarray containing more than 175,000 overlapping 15mer peptides derived from T. cruzi proteins. Peptides were synthesized in situ on microarray slides, spanning the complete length of 457 parasite proteins with fully overlapped 15mers (1 residue shift). Screening of these slides with antibodies purified from infected patients and healthy donors demonstrated both a high technical reproducibility as well as epitope mapping consistency when compared with earlier low-throughput technologies. Using a conservative signal threshold to classify positive (reactive) peptides we identified 2,031 disease-specific peptides and 97 novel parasite antigens, effectively doubling the number of known antigens and providing a tenfold increase in the number of fine mapped antigenic determinants for this disease. Finally, further analysis of the chip data showed that optimizing the amount of sequence overlap of displayed peptides can increase the protein space covered in a single chip by at least ~3 fold without sacrificing sensitivity. In conclusion, we show the power of high-density peptide chips for the discovery of pathogen-specific linear B-cell epitopes from clinical samples, thus setting the stage for high-throughput biomarker discovery screenings and proteome-wide studies of immune responses against pathogens.
    Original languageEnglish
    JournalMolecular & Cellular Proteomics
    Volume14
    Issue number7
    Pages (from-to)1871-1884
    Number of pages14
    ISSN1535-9484
    DOIs
    Publication statusPublished - 2015

    Bibliographical note

    Final version free via Creative Commons CC-BY license

    Fingerprint Dive into the research topics of 'Towards High-throughput Immunomics for Infectious Diseases: Use of Next-generation Peptide Microarrays for Rapid Discovery and Mapping of Antigenic Determinants'. Together they form a unique fingerprint.

    Cite this